This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Citigroup analyst Paul Lejuez downgraded the rating for Lululemon Athletica Inc. LULU from Buy to Neutral, while cutting the price target from $415 to $300. Lululemon shares settled at $272.06 on Wednesday. See how other analysts view this stock. See how other analysts view this stock.
Argus Research analyst Kevin Heal downgraded Zions Bancorporation ZION from Buy to Hold. Zions Bancorp shares closed at $50.98 on Wednesday. See how other analysts view this stock.
B of A Securities analyst Travis Steed downgraded the rating for Edwards Lifesciences Corporation EW from Buy to Neutral, while lowering the price target from $105 to $75. Edwards Lifesciences shares closed at $86.95 on Wednesday. See how other analysts view this stock.
Stifel analyst Matthew Smith downgraded Lamb Weston Holdings, Inc. LW from Buy to Hold and slashed the price target from $115 to $60. Lamb Weston shares closed at $56.42 on Wednesday. See how other analysts view this stock.
Needham analyst Quinn Bolton downgraded the rating for MaxLinear, Inc. MXL from Buy to Hold. MaxLinear shares closed at $22.29 on Wednesday. See how other analysts view this stock.